Acceleron Pharma Inc Logo Image

Acceleron Pharma Inc

Acceleron Pharma Inc Banner Image

Most Recent Annual Report

2017 Annual Report, Interactive Annual Report and Form 10K

Acceleron Pharma Inc

Acceleron Pharma Inc has reached its limit for free report views.

Order Free Hardcopy

You can request a free hardcopy of this report mailed to you by clicking the button below.

Add Annual Report

Archived Annual Reports

  • Acceleron Pharma Inc

    2016 Annual Report

  • Acceleron Pharma Inc

About Acceleron Pharma Inc

51-200 Employees
Based in Cambridge, Massachusetts

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes, and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol